Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cytosorbents Corp (CTSO)  
$1.28 0.05 (4.07%) as of 4:30 Mon 6/30


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 43,320,000
Market Cap: 55.45(M)
Last Volume: 407,634 Avg Vol: 404,351
52 Week Range: $0.7 - $1.55
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cytosorbents is engaged in the treatment of life-threatening conditions in the intensive care and cardiac surgery using blood purification via its proprietary polymer adsorption technology. Co. has several products commercialized and in development based on this technology platform. CytoSorb, Co.'s primary product, is approved in the European Union as an extracorporeal cytokine absorber, designed to reduce the cytokine storm that could otherwise cause massive inflammation, organ failure and death in common critical illnesses such as sepsis, burn injury, trauma, lung injury, cytokine release syndrome due to cancer immunotherapy, and pancreatitis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 20,000 252,325
Total Buy Value $0 $0 $19,294 $333,876
Total People Bought 0 0 1 9
Total Buy Transactions 0 0 1 11
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 243
  Page 1 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bator Michael G. Director   –       •      –    2025-02-24 4 A $1.13 $11,300 D/D 10,000 151,273     -
   Capponi Vincent President and COO   •       –      –    2025-02-24 4 A $1.13 $13,560 D/D 12,000 677,168     -
   Sobel Alan D. Director   –       •      –    2025-02-24 4 A $1.13 $24,804 D/D 21,950 145,757     -
   Mariani Peter J Chief Financial Officer   •       –      –    2025-02-24 4 A $1.13 $36,866 D/D 32,625 466,613     -
   Chan Phillip P. Chief Executive Officer   •       •      –    2025-02-24 4 A $1.13 $38,610 D/D 34,168 1,277,363     -
   Deliargyris Efthymios Chief Medical Officer   •       –      –    2025-01-17 4 OE $1.00 $16,233 D/D 16,233 403,025     -
   Bator Michael G. Director   –       •      –    2025-01-17 4 OE $1.00 $15,879 D/D 15,879 141,273     -
   Capponi Vincent President and COO   •       –      –    2025-01-17 4 OE $1.00 $31,760 D/D 31,760 665,168     -
   Chan Phillip P. Chief Executive Officer   •       •      –    2025-01-17 4 OE $1.00 $90,832 D/D 90,832 1,243,195     -
   Sobel Alan D. Director   –       •      –    2025-01-17 4 OE $1.00 $21,950 D/D 21,950 123,807     -
   Mariani Peter J Chief Financial Officer   •       –      –    2025-01-17 4 OE $1.00 $32,625 D/D 32,625 433,988     -
   Mariani Peter J Chief Financial Officer   •       –      –    2024-12-13 4 B $0.96 $19,294 D/D 20,000 401,363 2.74 8%     
   Mariani Peter J Chief Financial Officer   •       –      –    2024-08-14 4 A $0.00 $0 D/D 350,000 350,000     -
   Deliargyris Efthymios Chief Medical Officer   •       –      –    2024-04-02 4 A $0.00 $0 D/D 61,000 409,433     -
   Chan Phillip P. Chief Executive Officer   •       •      –    2024-04-02 4 A $0.00 $0 D/D 96,000 1,164,704     -
   Capponi Vincent President and COO   •       –      –    2024-04-02 4 A $0.00 $0 D/D 81,000 665,134     -
   Bloch Kathleen P. Chief Financial Officer   •       –      –    2024-04-02 4 A $0.00 $0 D/D 65,000 532,941     -
   Kim Jiny Director   –       •      –    2023-12-13 4 B $1.33 $10,000 D/D 7,519 77,819 2.39 -54%     
   Bator Michael G. Director   –       •      –    2023-12-13 4 B $1.33 $50,000 D/D 37,594 125,394 2.39 -54%     
   Deliargyris Efthymios Chief Medical Officer   •       –      –    2023-12-13 4 B $1.33 $30,001 D/D 22,557 348,433 2.74 -54%     
   Capponi Vincent President & COO   •       –      –    2023-12-13 4 B $1.33 $25,000 D/D 18,797 584,134 2.74 -54%     
   Chan Phillip P. Chief Executive Officer   •       •      –    2023-12-13 4 B $1.33 $100,000 D/D 75,188 1,068,704 2.81 -54%     
   Sobel Alan D. Director   –       •      –    2023-12-13 4 B $1.33 $30,001 D/D 22,557 101,857 2.39 -54%     
   Bloch Kathleen P. Chief Financial Officer   •       –      –    2023-12-13 4 B $1.33 $50,000 D/D 37,594 467,941 2.74 -54%     
   Jones Edward Raymond Director   –       •      –    2023-12-13 4 B $1.33 $10,000 D/D 7,519 88,834 2.39 -54%     
  243 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us